文献速递围术期管理与 ERAS

破裂腹主动脉瘤修复术后长期死亡与再干预:VQI与Medicare数据匹配分析

Long-term Mortality and Reintervention After Repair of Ruptured Abdominal Aortic Aneurysms Using VQI-matched Medicare Claims.
PubMed 文献 · Ann Surg · 2023-04-14

本研究基于VQI与Medicare理赔数据匹配,比较EVAR与OAR治疗破裂肾下腹主动脉瘤的死亡与再干预结局。共纳入1885例,EVAR组院内死亡率低于OAR(21% vs 37%),1年死亡率EVAR更优,但1年后无差异;EVAR再干预率在2年和5年更高,再干预与两组死亡率升高相关。

要点

  • EVAR组院内死亡率21%低于OAR组37%,围术期优势明显。
  • 1年死亡率EVAR优于OAR(HR 0.74),1年后两组无统计学差异。
  • EVAR再干预率在2年和5年高于OAR,再干预与死亡率升高相关。

核心结论

  • EVAR围术期死亡率优于OAR,但1年后长期死亡率相当。
  • EVAR再干预更常见,且再干预与两组死亡率升高相关。

研究设计与样本

  • VQI中2004-2018年破裂肾下腹主动脉瘤修复病例与Medicare理赔数据匹配(VQI-VISION)。
  • 共纳入1885例,OAR组790例,EVAR组1095例;中位年龄76岁,男性占73%。
  • 采用逆概率加权调整治疗选择,Cox比例风险模型和负二项回归分析,并对出院存活者进行Landmark分析。

主要发现

  • 院内死亡率EVAR组21% vs OAR组37%,OR 0.52(95%CI 0.4-0.7)。
  • 1年死亡率EVAR vs OAR的HR 0.74(95%CI 0.6-0.9),1年后HR 0.95(95%CI 0.8-1.2)。
  • 2年和5年再干预率EVAR vs OAR的率比分别为1.79(95%CI 1.2-2.7)和2.03(95%CI 1.4-3.0),第1年内无差异。
  • 再干预与死亡率升高相关:OAR组HR 1.66(95%CI 1.1-2.5),EVAR组HR 2.14(95%CI 1.6-2.9)。
  • 长期死亡率两组相似,HR 0.99(95%CI 0.8-1.2)。

临床怎么用

  • 破裂肾下腹主动脉瘤修复时,EVAR可降低围术期死亡率,但需告知患者远期再干预风险更高。
  • EVAR术后应加强随访监测,及时发现并处理再干预指征,以降低死亡风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The objective of this study was to compare endovascular aortic aneurysm repair (EVAR) versus open aortic repair (OAR) on mortality and reintervention after ruptured infrarenal abdominal aortic aneurysm (rAAA) repair in the Vascular Quality Initiative (VQI). BACKGROUND: The optimal treatment modality for rAAA remains debated, with little data on long-term comparisons. METHODS: VQI rAAA repairs (2004-2018) were matched with Medicare claims (VQI-VISION). Primary outcomes were in-hospital and long-term mortality. Secondary outcome was reintervention. Inverse probability weighting was used to adjust for treatment selection, and Cox Proportional Hazards models and negative binomial regressions were used for analysis. Landmark analysis was performed among patients surviving hospital discharge. RESULTS: Among 1885 VQI/Medicare rAAA patients, 790 underwent OAR, and 1095 underwent EVAR. Median age was 76 years; 73% were male. Inverse probability weighting produced comparable groups. In-hospital mortality was lower after EVAR versus OAR (21% vs 37%, odds ratio: 0.52, 95% CI, 0.4-0.7). One-year mortality rates were lower for EVAR versus OAR [hazard ratio (HR) 0.74, 95% CI, 0.6-0.9], but not statistically different after 1 year (HR: 0.95, 95% CI, 0.8-1.2). This implies additional benefits to EVAR in the short term. Reintervention rates were higher after EVAR than OAR at 2 and 5 years (rate ratio: 1.79 95% CI, 1.2-2.7 and rate ratio:2.03 95% CI, 1.4-3.0), but not within the first year. Reintervention was associated with higher mortality risk for both OAR (HR: 1.66 95% CI, 1.1-2.5) and EVAR (HR: 2.14 95% CI, 1.6-2.9). Long-term mortality was similar between repair types (HR: 0.99, 95% CI, 0.8-1.2). CONCLUSIONS: Within VQI/Medicare patients undergoing rAAA repair, the perioperative mortality rate favors EVAR but equalizes after 1 year. Reinterventions were more common after EVAR and were associated with higher mortality regardless of treatment.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Cirillo-Penn NC, Zheng X, Mao J, et al. Long-term Mortality and Reintervention After Repair of Ruptured Abdominal Aortic Aneurysms Using VQI-matched Medicare Claims. Ann Surg. 2023. PMID: 37057613. doi:10.1097/SLA.0000000000005876

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。